Strategic Corridor location is cited as long-term, mutually beneficial relationship

Jinyu Bio-technology Co., Ltd. (Jinyu), the largest animal vaccine company in China, announced today that it will open a vaccine research lab and office at the new K-State Office Park Phase II building in the KC Animal Health Corridor. The company will focus its Corridor location on research and design of vaccines for swine and cattle, as well as continuing education materials for Chinese companies and veterinarians. 
 
“Manhattan and Kansas State University are at the forefront of animal health research that is relevant to the Chinese animal agriculture industry and the world,” said Mr. Chongyu Zhang, chairman, Jinyu Bio-technology Co., Ltd. “Jinyu is the largest animal vaccine company in China and is fast growing internationally. We are looking forward to developing a long-term, mutually beneficial relationship with partners in the region.”  
 
Jinyu USA will partner with Kansas State University, the City of Manhattan and the State of Kansas to develop new animal health products that can be marketed in China, Asia, Africa and the U.S. The company is also considering the addition of future manufacturing facilities in the Corridor.   
 
“The addition of Jinyu Bio-technology to the KC Animal Health Corridor is truly a partnership of innovation and expertise,” said Kansas Commerce Secretary Antonio Soave. “We, as a state, must continue to engage excellent biotech companies like Jinyu, as Kansas continues to become one of the leading locations for bioscience in the nation.”
 
Jinyu plans a 2,400-sq. ft. lab facility, three offices and 800-sq. ft. of clean room space at the K-State Office Park Phase II building, employing four to six scientific researchers. The KSU Foundation will break ground on the Phase II building in July 2017 and the company’s space will become available in 2018.
 
“When university-focused companies like Jinyu Bio-technology Co., Ltd., locate adjacent to K-State’s campus, partnerships develop with faculty expertise and research to promote real-world application and discovery,” said Greg Willems, KSU Foundation president and CEO. “The K-State Office Park advances opportunity for these current and future collaborations to boldly move K-State — and the needs of a global community — forward.”
 
“Kansas State University has many partnerships with the industry, though this partnership is the first one with a Chinese animal health company,” said Jishu Shi, professor and director, U.S. China Center for Animal Health at Kansas State University. “It will accelerate the commercialization of novel discovery and development generated by K-State scientists.”
  
KCADC was proud to work with a number of regional partners in attracting Jinyu to the region: State of Kansas; Kansas Department of Commerce; City of Manhattan, Kansas; Manhattan, Kansas Area Chamber of Commerce; Kansas State University; Kansas State University Institute for Commercialization; Kansas State University Research Foundation; Kansas State University College of Veterinary Medicine; Kansas State University US-China Center for Animal Health; and the KC Animal Health Corridor. 
 
“The KC Animal Health Corridor’s international reputation is a strategic advantage for more and more animal health companies. We are thrilled to welcome Jinyu to our Corridor community and look forward to the company’s leadership in the effort,” said Kimberly Young, president of the KC Animal Health Corridor.

Comments are closed.